e-learning
resources
Paris 2018
Sunday, 16.09.2018
Pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of benzodiazepines in hospital readmissions and mortality in patients with chronic obstructive pulmonary disease
J. Teran Tinedo (Madrid, Spain), D. López Padilla (Madrid, Spain), A. Oliva Ramos (Madrid, Spain), W. Giron Matute (Madrid, Spain), L. Vicent Alaminos (Madrid, Spain), L. Puente Maestu (Madrid, Spain)
Source:
International Congress 2018 – Pharmacological management of COPD
Session:
Pharmacological management of COPD
Session type:
Thematic Poster
Number:
784
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Teran Tinedo (Madrid, Spain), D. López Padilla (Madrid, Spain), A. Oliva Ramos (Madrid, Spain), W. Giron Matute (Madrid, Spain), L. Vicent Alaminos (Madrid, Spain), L. Puente Maestu (Madrid, Spain). Effect of benzodiazepines in hospital readmissions and mortality in patients with chronic obstructive pulmonary disease. 784
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The rate of hospital admissions for chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 274s
Year: 2001
Predictors for admission to hospital in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2004 - Pulmonary rehabilitation in acute COPD exacerbations
Year: 2004
Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Readmission predictors in patients with chronic obstructive pulmonary disease hospitalized for an exacerbation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011
Hyperglycaemia and its association with outcomes in people admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 332s
Year: 2006
Hospital readmission rate and mortality after severe exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017
Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013
Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation
Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure
Year: 2003
Readmissions after hospitalization for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Cost analysis for inpatient therapy in elderly patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
The risk of repeated hospitalizations for exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2018 – Primary care management of COPD
Year: 2018
Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Regular basis visits and recovery of exacerbations, morbidity in patients with chronic obstructive pulmmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005
Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD
Source: Eur Respir J 2001; 17: 1138-1142
Year: 2001
N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 795-798
Year: 2003
Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept